Terms: = Germ cell tumor AND SDHB, PGL4, 6390, ENSG00000117118, SDH1, SDHIP, SDH, IP AND Prognosis
108 results:
1. [Clinical features of patients with metastatic pheochromocytoma/paraganglioma].
Cui YY; Zhou Y; Gao YJ; Li TY; Wang Y; Zhang WQ; Zhou T; Chen S; Tong AL
Zhonghua Yi Xue Za Zhi; 2024 Apr; 104(14):1174-1179. PubMed ID: 38583049
[No Abstract] [Full Text] [Related]
2. PSMA2 promotes glioma proliferation and migration via EMT.
Zhang Y; Xiang Z; Chen L; Deng X; Liu H; Peng X
Pathol Res Pract; 2024 Apr; 256():155278. PubMed ID: 38574629
[TBL] [Abstract] [Full Text] [Related]
3. Pan-cancer ion transport signature reveals functional regulators of glioblastoma aggression.
Bahcheli AT; Min HK; Bayati M; Zhao H; Fortuna A; Dong W; Dzneladze I; Chan J; Chen X; Guevara-Hoyer K; Dirks PB; Huang X; Reimand J
EMBO J; 2024 Jan; 43(2):196-224. PubMed ID: 38177502
[TBL] [Abstract] [Full Text] [Related]
4. Histone demethylase KDM4B accelerates the progression of glioblastoma via the epigenetic regulation of MYC stability.
Wang Z; Cai H; Li Z; Sun W; Zhao E; Cui H
Clin Epigenetics; 2023 Dec; 15(1):192. PubMed ID: 38093312
[TBL] [Abstract] [Full Text] [Related]
5. Associations of social vulnerability with truncal and extremity melanomas in the United States.
Goyal A; Fei-Zhang DJ; Pawlik TM; Bentrem DJ; Wayne JD
J Surg Oncol; 2024 Mar; 129(3):544-555. PubMed ID: 38009468
[TBL] [Abstract] [Full Text] [Related]
6. The survivin-ran inhibitor LLP-3 decreases oxidative phosphorylation, glycolysis and growth of neuroblastoma cells.
Galiger C; Zohora FT; Dorneburg C; Tews D; Debatin KM; Beltinger C
BMC Cancer; 2023 Nov; 23(1):1148. PubMed ID: 38007466
[TBL] [Abstract] [Full Text] [Related]
7. CircRNF10 triggers a positive feedback loop to facilitate progression of glioblastoma via redeploying the ferroptosis defense in GSCs.
Wang C; Zhang M; Liu Y; Cui D; Gao L; Jiang Y
J Exp Clin Cancer Res; 2023 Sep; 42(1):242. PubMed ID: 37723588
[TBL] [Abstract] [Full Text] [Related]
8. GSG2 facilitates the progression of human breast cancer through MDM2-mediated ubiquitination of E2F1.
Tang Y; Dai G; Yang Y; Liu H
J Transl Med; 2023 Aug; 21(1):523. PubMed ID: 37537694
[TBL] [Abstract] [Full Text] [Related]
9. CCNB1IP1 prevents ubiquitination-mediated destabilization of MYCN and potentiates tumourigenesis of MYCN-amplificated neuroblastoma.
Zhou Y; Yan H; Zhou Q; Wang P; Yang F; Yuan Z; Du Q; Zhai B
Clin Transl Med; 2023 Jul; 13(7):e1328. PubMed ID: 37461251
[TBL] [Abstract] [Full Text] [Related]
10. SDC1-TGM2-FLOT1-BHMT complex determines radiosensitivity of glioblastoma by influencing the fusion of autophagosomes with lysosomes.
Zeng L; Zheng W; Liu X; Zhou Y; Jin X; Xiao Y; Bai Y; Pan Y; Zhang J; Shao C
Theranostics; 2023; 13(11):3725-3743. PubMed ID: 37441590
[No Abstract] [Full Text] [Related]
11. Analyzing County-level Social Vulnerabilities of Head and Neck Melanomas in the United States.
McCampbell L; Fei-Zhang DJ; Chelius D; Rastatter J; Sheyn A
Laryngoscope; 2024 Jan; 134(1):185-190. PubMed ID: 37341511
[TBL] [Abstract] [Full Text] [Related]
12. S100 Calcium Binding Protein A16 Promotes cell Proliferation by triggering LATS1 ubiquitin degradation mediated by CUL4A ligase to inhibit Hippo pathway in Glioma development.
Hu Y; Zhang R; Lu S; Zhang W; Wang D; Ge Y; Jiang F; Qin X; Liu Y
Int J Biol Sci; 2023; 19(7):2034-2052. PubMed ID: 37151881
[No Abstract] [Full Text] [Related]
13. Prognostic association of immunoproteasome expression in solid tumours is governed by the immediate immune environment.
Kumar R; Dhaka B; Sahoo S; Jolly MK; Sabarinathan R
Mol Oncol; 2023 Jun; 17(6):1041-1059. PubMed ID: 37097039
[TBL] [Abstract] [Full Text] [Related]
14. Tumour microenvironment in pheochromocytoma and paraganglioma.
Martinelli S; Amore F; Canu L; Maggi M; Rapizzi E
Front Endocrinol (Lausanne); 2023; 14():1137456. PubMed ID: 37033265
[TBL] [Abstract] [Full Text] [Related]
15. Radiation induces IRAK1 expression to promote radioresistance by suppressing autophagic cell death via decreasing the ubiquitination of PRDX1 in glioma cells.
Li J; Sun Y; Zhao X; Ma Y; Xie Y; Liu S; Hui B; Shi X; Sun X; Zhang X
Cell Death Dis; 2023 Apr; 14(4):259. PubMed ID: 37031183
[TBL] [Abstract] [Full Text] [Related]
16. sdhb immunohistochemistry for prognosis of pheochromocytoma and paraganglioma: A retrospective and prospective analysis.
Su T; Yang Y; Jiang L; Xie J; Zhong X; Wu L; Jiang Y; Zhang C; Zhou W; Ye L; Ning G; Wang W
Front Endocrinol (Lausanne); 2023; 14():1121397. PubMed ID: 37008946
[TBL] [Abstract] [Full Text] [Related]
17. CEBPB upregulates P4HA2 to promote the malignant biological behavior in IDH1 wildtype glioma.
Wang S; Wu J; Zhao W; Li M; Li S
FASEB J; 2023 Apr; 37(4):e22848. PubMed ID: 36906285
[TBL] [Abstract] [Full Text] [Related]
18. Hypermethylation of HIC2 is a potential prognostic biomarker and tumor suppressor of glioma based on bioinformatics analysis and experiments.
Luo F; Liao Y; Cao E; Yang Y; Tang K; Zhou D; Zhou D; Cai H
CNS Neurosci Ther; 2023 Apr; 29(4):1154-1167. PubMed ID: 36650953
[TBL] [Abstract] [Full Text] [Related]
19. TNM Staging and Overall Survival in Patients With Pheochromocytoma and Sympathetic Paraganglioma.
Jimenez C; Ma J; Roman Gonzalez A; Varghese J; Zhang M; Perrier N; Habra MA; Graham P; Waguespack SG
J Clin Endocrinol Metab; 2023 Apr; 108(5):1132-1142. PubMed ID: 36433823
[TBL] [Abstract] [Full Text] [Related]
20. ARPC1B promotes mesenchymal phenotype maintenance and radiotherapy resistance by blocking TRIM21-mediated degradation of IFI16 and HuR in glioma stem cells.
Gao Z; Xu J; Fan Y; Zhang Z; Wang H; Qian M; Zhang P; Deng L; Shen J; Xue H; Zhao R; Zhou T; Guo X; Li G
J Exp Clin Cancer Res; 2022 Nov; 41(1):323. PubMed ID: 36380368
[TBL] [Abstract] [Full Text] [Related]
[Next]
